Veeral Sheth, MD, is joined by the director of marketing of eSight to discuss the 5th generation eSight Go, a device to enhance central vision functions in patients with a variety of eye diseases.
Sandforth discussed his research that found that early prediabetes remission conferred greater protective effects against T2D than later remission.
Study findings highlight the cost-effectiveness of more frequent HCV testing among people who inject drugs compared with no testing and less frequent testing.
In this video, the first in a 6-part series, panelists discuss recent advancements in PsO management.
These data resulted from a sub-study of the open-label extension (OLE) of the randomized, placebo-controlled phase 3 ‘Balance’ analysis.
Study findings highlight the cost-effectiveness of more frequent HCV testing among people who inject drugs compared with no testing and less frequent testing.
Our recap of Q2 2025 in cardiology spotlights 3 FDA headlines, trial news, and new episodes of Don’t Miss a Beat.
These data resulted from a sub-study of the open-label extension (OLE) of the randomized, placebo-controlled phase 3 ‘Balance’ analysis.
Lonsberry recommends alternative approaches to manage postoperative pain, balancing the need for relief against the risk of addiction and death.
New data from a UMichigan survey found that 8% of preventative aspirin users had not even discussed their use with any health care provider.
The prespecified analysis of FINEARTS-HF found finerenone’s impact on HF events, cardiovascular death, and symptoms was not impacted by frailty.
